C
Ansell Limited ANSLY
$106.18 $23.3828.24% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Ansell Limited is a global manufacturer of personal protective equipment (PPE) and safety solutions, serving healthcare, industrial, and life sciences markets. The company designs, manufactures, and distributes protective gloves, medical examination gloves, surgical gloves, body protection products, and related safety equipment used in environments where worker and patient protection are critical. Ansell operates primarily within the broader industrial safety, healthcare products, and occupational protection industries, with revenue driven largely by disposable and durable hand protection products sold to hospitals, laboratories, industrial operators, and distributors.

Founded in Australia in 1929 by Eric Norman Ansell, the company originally focused on rubber products before expanding into protective gloves and medical safety products through organic growth and acquisitions. Over several decades, Ansell evolved into a multinational PPE provider with a diversified portfolio spanning industrial and healthcare end markets. The company’s strategic positioning is supported by globally recognized safety brands, long-term distributor relationships, manufacturing scale across Asia and other regions, and expertise in material science and barrier protection technologies.

Business Operations

Ansell organizes its operations primarily through two major business segments: Healthcare Global Business Unit and Industrial Global Business Unit. The Healthcare Global Business Unit supplies surgical gloves, examination gloves, and cleanroom products to hospitals, healthcare systems, and life sciences customers. The Industrial Global Business Unit provides hand and body protection solutions for manufacturing, chemical processing, automotive, construction, mining, and energy sectors. Revenue is generated through direct enterprise sales and extensive distribution partnerships across developed and emerging markets.

The company maintains manufacturing facilities and supply chain operations across Asia-Pacific, particularly in Malaysia, Sri Lanka, Thailand, India, Vietnam, and China, while also operating distribution and commercial networks throughout North America, Europe, Latin America, and other international regions. Ansell controls proprietary glove technologies, chemical resistance formulations, and ergonomic safety designs through internal research and development capabilities. Important subsidiaries and brands include HyFlex, MICROFLEX, AlphaTec, TouchNTuff, and GAMMEX, which are widely used across industrial and medical settings.

Strategic Position & Investments

Ansell’s strategic direction has focused on expanding higher-margin specialty PPE categories, strengthening its healthcare and industrial safety portfolios, and improving supply chain resilience. The company has invested in automation, advanced manufacturing capabilities, and product innovation aimed at chemical protection, cleanroom applications, and high-performance industrial safety products. Growth initiatives have also emphasized premium branded solutions and penetration into regulated healthcare and life sciences environments.

The company has pursued acquisitions to broaden technology capabilities and product offerings. Notable transactions include the acquisition of Kimberly-Clark’s Personal Protective Equipment business and the acquisition of Ringers Gloves, which expanded Ansell’s presence in impact protection and oil-and-gas safety applications. Ansell has also continued investing in sustainability initiatives and material innovation, including products designed to reduce environmental impact and improve worker comfort. Public filings and investor disclosures indicate ongoing focus on operational efficiency, portfolio optimization, and expansion within specialized PPE markets.

Geographic Footprint

Ansell is headquartered in Melbourne, Australia, and maintains a broad international footprint with operations spanning more than 100 countries. The company generates substantial revenue from North America and Europe, while maintaining extensive manufacturing and sourcing capabilities across Asia-Pacific. Its global operating structure enables it to serve multinational healthcare systems, industrial manufacturers, and regional distribution networks.

The company’s influence is particularly strong in the global hand protection market, where it supplies products across healthcare, industrial, and scientific sectors. Ansell’s manufacturing concentration in Malaysia, Sri Lanka, Thailand, and other Asian markets supports cost-efficient production and access to global export infrastructure. Commercial offices, logistics hubs, and customer support operations are distributed across major economic regions, supporting localized market engagement and international customer relationships.

Leadership & Governance

Ansell Limited operates under a corporate governance structure overseen by its board of directors and executive leadership team. The company’s leadership strategy has emphasized innovation in worker safety, disciplined capital allocation, operational efficiency, and expansion into specialized PPE categories with stronger long-term demand characteristics. Governance practices are informed by Australian corporate regulatory standards and disclosures contained in SEC filings and Australian Securities Exchange reporting.

Key executives include:

  • Neil Salmon – Chief Executive Officer and Managing Director
  • Zubair Javeed – Chief Financial Officer
  • Julie O’Donnell – Senior Vice President and General Counsel
  • Marina Bellini – President and General Manager, Healthcare Global Business Unit
  • Jeffrey George – President and General Manager, Industrial Global Business Unit

Information regarding executive responsibilities and organizational structure has been corroborated through company annual reports, investor materials, and public regulatory disclosures. Where executive role transitions or reporting structures differ across reporting periods, data reflects the most recently available public information.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $218.36
B
AAPL NASDAQ $326.57
B
AVGO NASDAQ $360.83
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $105.73
A
Top Financial Stocks
See All »
B
B
JPM NYSE $353.56
B
V NYSE $367.21
Top Health Care Stocks
See All »
B
LLY NYSE $1,123.00
B
JNJ NYSE $266.35
B
ABBV NYSE $255.00
Top Real Estate Stocks
See All »
B
PLD NYSE $134.41
B
EQIX NASDAQ $1,023.81